Vascular Biogenics Ltd. Company Profile

21:08 EST 16th February 2020 | BioPortfolio

Vascular Biogenics Ltd. (VBL) is a biopharmaceutical company focused on developing novel treatments for pathologies in which vascular biology plays a critical role. Based on its leading research expertise in vascular biology VBL has developed lead candidates in the fields of cardiovascular health and solid tumor cancer treatment.
Cardiovascular Health: Attacking Atherosclerosis through Anti-Inflammation

VBL's lead cardiovascular drug candidate, CI-201, has been developed as a solution to the overwhelming need for an anti-inflammatory anti-atherosclerosis treatment. In preclinical trials CI-201 has been shown to significantly reduce disease progression by modulating inflammation associated with atherosclerosis. Furthermore, the use of CI-201 in combination therapy with existing lipid-lowering drugs should allow patients to benefit from multiple routes of treatment.

VBL is investigating the application of CI-201 in other inflammatory based diseases such as Rheumatoid Arthritis and Multiple Sclerosis.


6 Jonathan Netanyahu St
Or Yehuda


Phone: 972-3-634-6450
Fax: 972-3-634-6449

News Articles [313 Associated News Articles listed on BioPortfolio]

Vascular Biogenics' (VBLT) CEO Dror Harats on Q2 2019 Results - Earnings Call Transcript

Vascular Biogenics Ltd. VBLT) CEO Dror Harats on Q3 2019 Results - Earnings Call Transcript

A multicentric study identifies a new biomarker for vascular dementias

(IDIBELL-Bellvitge Biomedical Research Institute) Lipocalin 2 strongly emerges as a possible new biomarker for vascular dementia. The increase of this protein in the cerebrospinal fluid has been valid...

Intact Vascular expands tack endovascular system portfolio offering

Intact Vascular, developer of medical devices for minimally invasive peripheral vascular procedures, today announced Food and Drug Administration PMA approval for the expansion of its Tack Endovascula...

Vaping less harmful than smoking for vascular health, major study finds

(University of Dundee) Study finds significant improvements in vascular health of chronic smokers who transition to e-cigarettes. Women see greater health benefits than men following switch to e-cigar...

LeMaitre buys Applied Medical's vascular clot management biz

LeMaitre Vascular Inc. is paying $14.2mm--$11mm up front and $3.2mm in two later installments ($2mm in 12 months and $1.2m in 24 months)--to acquire Applied Medical Resources Corp.’s vascular clot m...

Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System – a Mechanical Device for Treatment of DVT

ANAHEIM, Calif. (PRWEB) December 06, 2019 Southern California medical device manufacturer Vascular Medcure, Inc. has received FDA 51...

Israeli Study Finds Immunotherapies Increase Risk of Acute Vascular Events

Following administration of checkpoint inhibitor therapy, 2.6% of patients experienced an acute vascular event within 6 months of starting treatment.

Drugs and Medications [0 Results]


PubMed Articles [1221 Associated PubMed Articles listed on BioPortfolio]

An updated physician workforce model predicts a shortage of vascular surgeons for the next 20 years.

Concern regarding the adequacy of the vascular surgery workforce persists. We aimed to predict future vascular surgery workforce size and capacity using contemporary data on the U.S. population and nu...

Title: Variability in non-invasive vascular laboratory experience of vascular surgery training programs based on survey of trainees suggests need for standardized curriculum.

Although Registered Physician in Vascular Interpretation (RPVI) certification is required for vascular surgery board certification, no standardized noninvasive vascular laboratory (NIVL) curriculum fo...

Retinal vascular fractal dimension and cerebral blood flow, a pilot study.

Ocular and brain microcirculation share embryological and histological similarities. The retinal vascular fractal dimension (FD) is a marker of retinal vascular complexity of the vascular tree. The pu...

Peripheral Vascular Anomalies - Essentials in Periinterventional Imaging.

 Peripheral vascular anomalies represent a rare disease with an underlying congenital mesenchymal and angiogenetic disorder. Vascular anomalies are subdivided into vascular tumors and vascular malfo...

Knowledge gain of the non-vascular surgeons after attending a course on traumatic vascular emergencies.

To measure the effectiveness of the workshop in enhancing the knowledge and skills of the non-vascular surgeons in dealing with traumatic vascular emergencies.

Clinical Trials [2427 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)

The purpose of this study is to determine the onset of action of two commercially available over-the-counter antihistamines (Loratadine and Fexofenadine) in a model of seasonal allergic r...

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Reduced antiplatelet activity (low response (LR)/high on-treatment platelet reactivity (HPR)) of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic e...

A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population

SafeBreak Vascular is a medical device indicated for fluid flow control during the administration of IV fluids/medication to the patient's vascular system and to aid in the prevention of u...

Companies [343 Associated Companies listed on BioPortfolio]

Vascular Biogenics Ltd.

Vascular Biogenics Ltd. (VBL) is a biopharmaceutical company focused on developing novel treatments for pathologies in which vascular biology plays a critical role. Based on its leading research exper...

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...

The Foundation for Accelerated Vascular Research

The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...

Society for Vascular Surgery

The Society for Vascular Surgery (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health thr...

Vascular Nanotransfer Technologies

Privately held VNT, based in Auburndale, Mass., is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of c...

More Information about "Vascular Biogenics Ltd." on BioPortfolio

We have published hundreds of Vascular Biogenics Ltd. news stories on BioPortfolio along with dozens of Vascular Biogenics Ltd. Clinical Trials and PubMed Articles about Vascular Biogenics Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vascular Biogenics Ltd. Companies in our database. You can also find out about relevant Vascular Biogenics Ltd. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record